FlexifyMe Raises ₹20 Crore to Expand AI-Powered Physiotherapy and Chronic Pain Care

FlexifyMe, an AI-powered healthtech company focused on physiotherapy and chronic pain management, has raised ₹20 crore in a pre-Series A funding round led by IvyCap Ventures, with participation from Signal Ventures and existing investors.

The new funding will support FlexifyMe’s hybrid care expansion through online and offline centres, the launch of posture and gait analysis labs, and deeper clinical research collaborations.

The company leverages AI-driven diagnostics, physiotherapy, and personalised care plans to address chronic musculoskeletal pain and improve long-term patient outcomes.

Manjeet Singh, Co-Founder of FlexifyMe, said, “Our mission is simple but ambitious: help people live pain-free by identifying and fixing root causes — not just masking symptoms. For decades, physiotherapy has too often relied on quick fixes and subjective assessments. We’re changing that. By combining technology, licensed physiotherapists and rigorous progress tracking, we are making the journey to a pain-free life scientific, objective and measurable.”

Previously, FlexifyMe raised a $1 million seed round led by Flipkart Ventures and gained national visibility on Shark Tank India Season 3, where it secured investment from Namita Thapar (Emcure).

Amit Bhayani, Co-Founder, explained, “Our technology — dynamic posture and gait analysis with AI — allows clinicians to pinpoint biomechanical root causes and design programs that are tracked weekly and monthly. Outcomes matter — and with objective tracking we can show what’s working and continuously improve care pathways.”

Vikram Gupta, Founder and Managing Partner of IvyCap Ventures, said, “FlexifyMe is pioneering a new frontier in digital health by making physiotherapy and chronic care more accessible, measurable, and impactful. Their unique combination of AI-driven technology and expert-led therapy has strong global applicability.”